Dr. Joseph W. Kim, MD
Claim this profileYale University
Studies Prostate Cancer
Studies Bladder Cancer
14 reported clinical trials
27 drugs studied
Area of expertise
1Prostate Cancer
Stage IV
BRCA1 positive
BRCA2 positive
2Bladder Cancer
Stage IV
Stage III
TSC2 positive
Affiliated Hospitals
Clinical Trials Joseph W. Kim, MD is currently running
ACR-368
for Ovarian Cancer
This trial tests a new drug, ACR-368, alone or with a small dose of another drug, gemcitabine, in patients whose cancers don't respond to standard treatments. A special test helps decide which treatment might work best for each patient. Gemcitabine has been used with other drugs for various cancers, including pancreatic, lung, ovarian, and breast cancers.
Recruiting1 award Phase 210 criteria
Sipuleucel-T + BAT
for Prostate Cancer
This is an open-label, single-arm phase II study of bipolar androgen therapy (BAT) given in addition with standard of care Sipuleucel-T to determine the interferon (IFN) gamma Enzyme-linked Immunospot (ELISPOT) response rate to PA2024 (an engineered fusion protein of prostatic acid phosphatase and granulocyte-macrophage colony-stimulating factor which the activated autologous dendritic cells in the Sipuleucel-T vaccine are loaded with) in patients with metastatic castration resistant prostate cancer (mCRPC).
Recruiting1 award Phase 223 criteria
More about Joseph W. Kim, MD
Clinical Trial Related9 years of experience running clinical trials · Led 14 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Joseph W. Kim, MD has experience with
- Olaparib
- Gemcitabine
- Cediranib
- Cediranib Maleate
- Sapanisertib
- Sipuleucel-T
Breakdown of trials Joseph W. Kim, MD has run
Prostate Cancer
Bladder Cancer
Prostate Adenocarcinoma
Transitional Cell Carcinoma
Urothelial Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Joseph W. Kim, MD specialize in?
Joseph W. Kim, MD focuses on Prostate Cancer and Bladder Cancer. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are BRCA1 positive.
Is Joseph W. Kim, MD currently recruiting for clinical trials?
Yes, Joseph W. Kim, MD is currently recruiting for 6 clinical trials in New Haven Connecticut. If you're interested in participating, you should apply.
Are there any treatments that Joseph W. Kim, MD has studied deeply?
Yes, Joseph W. Kim, MD has studied treatments such as Olaparib, Gemcitabine, Cediranib.
What is the best way to schedule an appointment with Joseph W. Kim, MD?
Apply for one of the trials that Joseph W. Kim, MD is conducting.
What is the office address of Joseph W. Kim, MD?
The office of Joseph W. Kim, MD is located at: Yale University, New Haven, Connecticut 06520 United States. This is the address for their practice at the Yale University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.